Clinical implementation of cell‐free DNA‐based aneuploidy screening: perspectives from a national audit

This publication has 29 references indexed in Scilit:

• Impact of noninvasive prenatal testing in regionally dispersed medical centers in the United States
  American Journal of Obstetrics and Gynecology, 2014
• Analysis of Cell-Free DNA in Maternal Blood in Screening for Aneuploidies: Meta-Analysis
  Fetal Diagnosis and Therapy, 2014
• Clinical implementation of noninvasive prenatal testing among maternal fetal medicine specialists
  Prenatal Diagnosis, 2013
• ACMG statement on noninvasive prenatal screening for fetal aneuploidy
  Genetics in Medicine, 2013
• Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis
  Prenatal Diagnosis, 2013
• Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples
  Prenatal Diagnosis, 2013
• Clinical experience of noninvasive prenatal testing with cell‐free DNA for fetal trisomies 21, 18, and 13, in a general screening population
  Prenatal Diagnosis, 2013
• Committee Opinion No. 545
  Obstetrics & Gynecology, 2012
• Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population
  American Journal of Obstetrics and Gynecology, 2012
• Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011
  Prenatal Diagnosis, 2012